Citations (89)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Adam Al-Hakim, Anoop Mistry & Sinisa Savic. (2022) Improving Diagnosis and Clinical Management of Acquired Systemic Autoinflammatory Diseases. Journal of Inflammation Research 15, pages 5739-5755.
Read now
Read now
Yuko Kaneko & Tsutomu Takeuchi. (2022) Interleukin-6 inhibition: a therapeutic strategy for the management of adult-onset Still’s disease. Expert Opinion on Biological Therapy 22:1, pages 79-85.
Read now
Read now
Paolo Sfriso, Sara Bindoli, Andrea Doria, Eugen Feist & Paola Galozzi. (2020) Canakinumab for the treatment of adult-onset Still’s disease. Expert Review of Clinical Immunology 16:2, pages 129-138.
Read now
Read now
Santos Castañeda, Dolores Martínez-Quintanilla, José L. Martín-Varillas, Noelia García-Castañeda, Belén Atienza-Mateo & Miguel A. González-Gay. (2019) Tocilizumab for the treatment of adult-onset Still’s disease. Expert Opinion on Biological Therapy 19:4, pages 273-286.
Read now
Read now
Santos Castañeda, Belén Atienza-Mateo, José L. Martín-Varillas, José M. Serra López-Matencio & Miguel A. González-Gay. (2018) Anakinra for the treatment of adult-onset Still’s disease. Expert Review of Clinical Immunology 14:12, pages 979-992.
Read now
Read now
Piero Ruscitti & Roberto Giacomelli. (2018) Pathogenesis of adult onset still’s disease: current understanding and new insights. Expert Review of Clinical Immunology 14:11, pages 965-976.
Read now
Read now
Yubo Ma, Meng Wu, Xu Zhang, Qing Xia, Jiajia Yang, Shengqian Xu & Faming Pan. (2018) Efficacy and safety of tocilizumab with inhibition of interleukin-6 in adult-onset Still’s disease: A meta-analysis. Modern Rheumatology 28:5, pages 849-857.
Read now
Read now
Serena Colafrancesco, Roberta Priori & Guido Valesini. (2015) Presentation and diagnosis of adult-onset Still’s disease: the implications of current and emerging markers in overcoming the diagnostic challenge. Expert Review of Clinical Immunology 11:6, pages 749-761.
Read now
Read now
Der-Yuan Chen. (2013) Recent advances in the treatment of adult-onset Still's disease. Expert Opinion on Orphan Drugs 1:2, pages 103-113.
Read now
Read now
K. J. Evensen, T. J. G. Swaak & J. C. Nossent. (2007) Increased ferritin response in adult Still's disease: specificity and relationship to outcome. Scandinavian Journal of Rheumatology 36:2, pages 107-110.
Read now
Read now
D Testa, S Bilia, AG Tavoni & P Migliorini. Adult-onset Still’s disease: analysis of a monocentric cohort of patients. Scandinavian Journal of Rheumatology 0:0, pages 1-6.
Read now
Read now
Articles from other publishers (78)
Piero Ruscitti, Dennis McGonagle, Viviam Canon Garcia, Hilde Rabijns, Katrin Toennessen, Mary Chappell, Mary Edwards, Paul Miller, Neil Hansell, Joe Moss, Sara Graziadio & Eugen Feist. (2024) Systematic Review and Metaanalysis of Pharmacological Interventions in Adult-Onset Still Disease and the Role of Biologic Disease-Modifying Antirheumatic Drugs. The Journal of Rheumatology 51:5, pages 442-451.
Crossref
Crossref
Eleonore de Fritsch, Fabienne Louis-Sidney, Arthur Felix, Florence Moinet, Cécile Bagoée, Kim Henry, Sophie Wolff, Katlyne Polomat, Moustapha Dramé, Christophe Deligny & Benoit Suzon. (2023) Epidemiology, characteristics, treatments, and outcomes of adult-onset Still's disease in Afro-Caribbeans: Results from a population-based study in Martinique, French West Indies. Journal of Autoimmunity 139, pages 103086.
Crossref
Crossref
Shih-Hsin Chang, Teng-Chieh Hsu, Po-Hao Huang, Chien-Chung Huang, Kai-Jieh Yeo, Wei-Jhe Hong, Po-Ku Chen, Yun-Hsieh Lin, Joung-Liang Lan & Der-Yuan Chen. (2022) A Streamlined Diagnostic Process Improved the Outcomes of Patients with Adult-Onset Still’s Disease: A Single-Center Retrospective Observational Study. Rheumatology and Therapy 10:2, pages 343-355.
Crossref
Crossref
Karima Daghor-Abbaci, Nadia Ait Hamadouche, Chafia Dahou Makhloufi, Farida Mechid, Fifi Otmani, Mohamed Makrelouf, Amel Otmane, Nourredine Smail, Malika Boucelma, Fatma Zohra Aissat, Salima Lefkir-Teffiani, Bilel Bengana, Nadia Boukheris, Amar Tebaibia, Baya Taharbouchet, Soraya Ayoub, Brahim Benziane, Nadia Oumnia, Chafika Haouichet, Fella Hanni, Nazim Laraba, Djennete Hakem, Nacera Benfenatki & Abdelkrim Berrah. (2023) Proposal of a new diagnostic algorithm for adult-onset Still’s disease. Clinical Rheumatology 42:4, pages 1125-1135.
Crossref
Crossref
Maxime N. Gottschalk, Max Heiland, Susanne Nahles, Robert Preissner, William A. Petri, Stephanie Wendy & Saskia Preissner. (2023) Increased incidence of adult-onset Still’s disease in association with COVID-19 vaccination and SARS-CoV-2 infection. Orphanet Journal of Rare Diseases 18:1.
Crossref
Crossref
Zainab Qudsiya & Donica L Baker. (2023) The Great Still-Usion: Unmasking Adult-Onset Still’s Disease Masquerading As Upper Respiratory Tract Infection. Cureus.
Crossref
Crossref
Stefan Vordenbäumen, Eugen Feist, Jürgen Rech, Martin Fleck, Norbert Blank, Johannes-Peter Haas, Ina Kötter, Martin Krusche, Gamal Chehab, Bimba Hoyer, Uta Kiltz, Dorothea Fell, Julia Reiners, Christiane Weseloh, Matthias Schneider & Jürgen Braun. (2022) Diagnosis and treatment of adult-onset Still’s disease: a concise summary of the German society of rheumatology S2 guidelineDiagnostik und Behandlung bei M. Still des Erwachsenen: kurze Zusammenfassung der S2-Leitlinie der Deutschen Gesellschaft für Rheumatologie. Zeitschrift für Rheumatologie 82:S2, pages 81-92.
Crossref
Crossref
Po-Ku Chen, Tsai-Ling Liao, Shih-Hsin Chang, Kai-Jieh Yeo, Chia-Hui Chou & Der-Yuan Chen. (2023) High-titer anti-interferon-γ neutralizing autoantibodies linked to opportunistic infections in patients with adult-onset still's disease. Frontiers in Medicine 9.
Crossref
Crossref
Stefan Vordenbäumen, Eugen Feist, Jürgen Rech, Martin Fleck, Norbert Blank, Johannes-Peter Haas, Ina Kötter, Martin Krusche, Gamal Chehab, Bimba Hoyer, Uta Kiltz, Dorothea Fell, Julia Reiners, Christiane Weseloh, Matthias Schneider & Jürgen Braun. (2022) DGRh-S2e-LeitlinieDGRh S2e guidelines. Zeitschrift für Rheumatologie 81:S1, pages 1-20.
Crossref
Crossref
Johannes Nossent, Warren Raymond, Helen Keen, David B. Preen & Charles A. Inderjeeth. (2022) Adult‐onset Still's disease in Western Australia: Epidemiology, comorbidity and long‐term outcome. International Journal of Rheumatic Diseases 25:11, pages 1306-1314.
Crossref
Crossref
Samar O. Alharbi. (2022) COVID-19 in a patient with new adult-onset Still disease: A case report. Medicine 101:40, pages e30953.
Crossref
Crossref
Jasper F. Nies, Udo Schneider & Martin Krusche. (2022) Rare, rarer, lung involvement in adult-onset Still's disease: A mini-review. Frontiers in Medicine 9.
Crossref
Crossref
Shijia Rao, Lemuel Shui-Lun Tsang, Ming Zhao, Wei Shi & Qianjin Lu. (2022) Adult-onset Still’s disease: A disease at the crossroad of innate immunity and autoimmunity. Frontiers in Medicine 9.
Crossref
Crossref
Karima Daghor Abbaci, Nadia Ait Hamadouche, Fifi Otmani, Chafia Dahou Makhloufi, Farida Mechid, Mohamed Makrelouf, Amel Otmane, Nourredine Smail, Malika Boucelma, Fatma Zohra Aissat, Salima Lefkir-Teffiani, Bilel Bengana, Nadia Boukheris, Amar Tebaibia, Baya Taharbouchet, Soraya Ayoub, Brahim Benziane, Nadia Oumnia, Chafika Haouichet, Fella Hanni, Nazim Laraba, Djennete Hakem, Nacera BenfenatkiAbdelkrim Berrah. (2022) Validation of the neutrophil-to-lymphocyte ratio as a new simple biomarker of adult onset Still’s disease: A STROBE-Compliant prospective observational study. Medicine 101:32, pages e29970.
Crossref
Crossref
Reda A. Elhawary, Mir Nadeem, Mohammed S. Abdelwahed, Mansour Somaily & Shahenda Y. Alemam. (2022) Adult-Onset Still’s Disease with Dermatopathic Lymphadenitis Clinicopathologic Features: A Rare Case Report and Review of the Literature. Case Reports in Immunology 2022, pages 1-5.
Crossref
Crossref
Yuko Kaneko. (2022) Interluekin-6 inhibitors for the treatment of adult-onset Still’s disease. Modern Rheumatology 32:1, pages 12-15.
Crossref
Crossref
Petros Efthimiou, Olga Petryna, Priscila Nakasato & Apostolos Kontzias. (2022) New insights on multigenic autoinflammatory diseases. Therapeutic Advances in Musculoskeletal Disease 14, pages 1759720X2211178.
Crossref
Crossref
Clément Javaux, Thomas El-Jammal, Pierre-Antoine Neau, Nicolas Fournier, Mathieu Gerfaud-Valentin, Laurent Perard, Marine Fouillet-Desjonqueres, Julie Le Scanff, Emmanuelle Vignot, Stéphane Durupt, Arnaud Hot, Alexandre Belot, Isabelle Durieu, Thomas Henry, Pascal Sève & Yvan Jamilloux. (2021) Detection and Prediction of Macrophage Activation Syndrome in Still’s Disease. Journal of Clinical Medicine 11:1, pages 206.
Crossref
Crossref
Rui Li, Xiaolei Liu, Guangliang Chen, Guo Tang, Xiaoxiang Chen, Xuesong Liu, Juan Wang & Liangjing Lu. (2021) Clinical phenotypes and prognostic factors of adult-onset Still’s disease: data from a large inpatient cohort. Arthritis Research & Therapy 23:1.
Crossref
Crossref
Julián M. Cota-Arce, Jonhatan Cota, Marco A. De León-Nava, Alexia Hernández-Cáceres, Leopoldo I. Moncayo-Salazar, Fidel Valle-Alvarado, Vera L. Cordero-Moreno, Karen L. Bonfil-Solis, Jesús E. Bichara-Figueroa, José Hernández-Hernández & Luis Villela. (2021) Efficacy and safety of canakinumab in the treatment of adult-onset Still's disease: A systematic review. Seminars in Arthritis and Rheumatism 51:6, pages 1282-1290.
Crossref
Crossref
Po-Ku Chen, Kai-Jieh Yeo, Po-Hao Huang, Shih-Hsin Chang, Ching-Kun Chang, Joung-Liang Lan & Der-Yuan Chen. (2021) Increased Lipid Peroxidation May Be Linked to Ferritin Levels Elevation in Adult-Onset Still’s Disease. Biomedicines 9:11, pages 1508.
Crossref
Crossref
Aida Malek Mahdavi, Afshin Khalili, Samin Alihosseini, Mehran Jaberinezhad, Kamal Esalatmanesh, Mehrzad Hajialilo, Seyedmostafa Seyedmardani & Alireza Khabbazi. (2021) Efficacy of tight control strategy in the treatment of adult-onset Still disease. Clinical Rheumatology 40:10, pages 3941-3949.
Crossref
Crossref
Yuning Ma, Jianfen Meng, Jinchao Jia, Mengyan Wang, Jialin Teng, Dehao Zhu, Chengde Yang & Qiongyi Hu. (2021) Current and emerging biological therapy in adult-onset Still’s disease. Rheumatology 60:9, pages 3986-4000.
Crossref
Crossref
Judith Leyens, Tim Th. A. Bender, Martin Mücke, Christiane Stieber, Dmitrij Kravchenko, Christian Dernbach & Matthias F. Seidel. (2021) The combined prevalence of classified rare rheumatic diseases is almost double that of ankylosing spondylitis. Orphanet Journal of Rare Diseases 16:1.
Crossref
Crossref
Anis Mzabi, Rym Fakhfakh, Maissa Thabet, Imen Ben Hassine, Jihed Anoun, Monia Karmani, Fatma Ben Fredj & Chadia Laouani. (2021) Elderly-onset adult Still’s disease. Rheumatology 59:3, pages 188-196.
Crossref
Crossref
Po-Ku Chen & Der-Yuan Chen. (2021) An Update on the Pathogenic Role of Macrophages in Adult-Onset Still’s Disease and Its Implication in Clinical Manifestations and Novel Therapeutics. Journal of Immunology Research 2021, pages 1-11.
Crossref
Crossref
Wei-Ting Hung, Shuen-Iu Hung, Yi-Ming Chen, Chia-Wei Hsieh, Hsin-Hua Chen, Kuo-Tung Tang, Der-Yuan Chen & Tsuo-Hung Lan. (2021) The Association of ATG16L1 Variations with Clinical Phenotypes of Adult-Onset Still’s Disease. Genes 12:6, pages 904.
Crossref
Crossref
Wei-Ting Hung, Yi-Ming Chen, Shuen-Iu Hung, Hsin-Hua Chen, Ning-Rong Gung, Chia-Wei Hsieh, Kuo-Tung Tang & Der-Yuan Chen. (2021) CARD8 SNP rs11672725 Identified as a Potential Genetic Variant for Adult-Onset Still’s Disease. Life 11:5, pages 382.
Crossref
Crossref
Mirna Reihl Crnogaj, Darija Čubelić, Antonija Babić, Miroslav Mayer & Branimir Anić. (2020) Treatment of refractory adult onset Still’s disease with tocilizumab—a single centre experience and literature review. Rheumatology International 40:8, pages 1317-1325.
Crossref
Crossref
Estefanía Calle-Botero, María Fernanda Corrales-Sierra, Lina María Ballesteros-García, Carolina Muñoz-Grajales, Javier Darío Márquez-Hernández, Andrés Felipe Echeverri-García, Luis Fernando Pinto-Peñaranda, Miguel Antonio Mesa-Navas & Carlos Jaime Velásquez-Franco. (2020) Enfermedad de Still del adulto: características clínicas y pronóstico de una cohorte de pacientes colombianos. Revista de la Facultad de Medicina 68:2.
Crossref
Crossref
Yi-Ming Chen, Wei-Ting Hung, Wan-Chun Chang, Chia-Wei Hsieh, Wen-Hung Chung, Joung-Liang Lan, Ning-Rong Gung, Yun-Shien Lee, Der-Yuan Chen & Shuen-Iu Hung. (2020) Genetic Association and Expression Correlation between Colony-Stimulating Factor 1 Gene Encoding M-CSF and Adult-Onset Still’s Disease. Journal of Immunology Research 2020, pages 1-11.
Crossref
Crossref
M. Delplanque, J. Pouchot, S. Ducharme-Bénard, B.J Fautrel, A. Benyamine, L. Daniel, T. Gendre, G. Grateau & S. Georgin-Lavialle. (2020) AA amyloidosis secondary to adult onset Still's disease: About 19 cases. Seminars in Arthritis and Rheumatism 50:1, pages 156-165.
Crossref
Crossref
Sheng Li, Siting Zheng, Shunli Tang, Yunlei Pan, Shan Zhang, Hong Fang & Jianjun Qiao. (2019) Autoinflammatory Pathogenesis and Targeted Therapy for Adult-Onset Still’s Disease. Clinical Reviews in Allergy & Immunology 58:1, pages 71-81.
Crossref
Crossref
Meng-Yan Wang, Jin-Chao Jia, Cheng-De Yang & Qiong-Yi Hu. (2019) Pathogenesis, disease course, and prognosis of adult-onset Still's disease: an update and review. Chinese Medical Journal 132:23, pages 2856-2864.
Crossref
Crossref
Holger Kudela, Susanne Drynda, Anke Lux, Gerd Horneff & Joern Kekow. (2019) Comparative study of Interleukin-18 (IL-18) serum levels in adult onset Still’s disease (AOSD) and systemic onset juvenile idiopathic arthritis (sJIA) and its use as a biomarker for diagnosis and evaluation of disease activity. BMC Rheumatology 3:1.
Crossref
Crossref
Bella Y. Mehta, Said Ibrahim, William Briggs & Petros Efthimiou. (2019) Racial/Ethnic variations in morbidity and mortality in Adult Onset Still's Disease: An analysis of national dataset. Seminars in Arthritis and Rheumatism 49:3, pages 469-473.
Crossref
Crossref
María Lorena Brance. (2019) Rapid responses to golimumab in refractory adult-onset Still's disease: A case report and review of the literature. Revista Colombiana de Reumatología (English Edition) 26:4, pages 271-275.
Crossref
Crossref
María Lorena Brance. (2019) Rapid responses to golimumab in refractory adult-onset Still's disease: A case report and review of the literature. Revista Colombiana de Reumatología 26:4, pages 273-277.
Crossref
Crossref
Cody Schwartz, Altelisha Taylor & Zareen Zaidi. (2018) Expand the differential…think beyond rheumatoid arthritis. BMJ Case Reports, pages bcr-2018-225618.
Crossref
Crossref
Paola Galozzi, Chiara Baggio, Sara Bindoli, Francesca Oliviero & Paolo Sfriso. (2018) Development and Role in Therapy of Canakinumab in Adult-Onset Still’s Disease. Frontiers in Pharmacology 9.
Crossref
Crossref
V. V. Lebedeva & Yu. V. Muravyev. (2018) CHARACTERISTICS OF ADULT-ONSET STILL’S DISEASE IN THE 21ST CENTURY. Rheumatology Science and Practice 56:4, pages 506-514.
Crossref
Crossref
Roberto Giacomelli, Piero Ruscitti & Yehuda Shoenfeld. (2018) A comprehensive review on adult onset Still's disease. Journal of Autoimmunity 93, pages 24-36.
Crossref
Crossref
Paolo Sfriso, Sara Bindoli & Paola Galozzi. (2018) Adult-Onset Still’s Disease: Molecular Pathophysiology and Therapeutic Advances. Drugs 78:12, pages 1187-1195.
Crossref
Crossref
M. Z. Kanevskaya & T. B. Kondratyeva. (2018) STILL’S DISEASE IN A DULTS (CLINICAL CASES). The Clinician 12:1, pages 57-62.
Crossref
Crossref
Yvan Jamilloux, Alexandre Belot, Flora Magnotti, Sarah Benezech, Mathieu Gerfaud-Valentin, Emilie Bourdonnay, Thierry Walzer, Pascal Sève & Thomas Henry. (2017) Geoepidemiology and Immunologic Features of Autoinflammatory Diseases: a Comprehensive Review. Clinical Reviews in Allergy & Immunology 54:3, pages 454-479.
Crossref
Crossref
Ralph Yachoui. (2018) PURTSCHER-LIKE RETINOPATHY ASSOCIATED WITH ADULT-ONSET STILL DISEASE. RETINAL Cases & Brief Reports 12:4, pages 379-381.
Crossref
Crossref
Marcello Govoni, Alessandra Bortoluzzi, Daniela Rossi & Vittorio Modena. (2017) How I treat patients with adult onset Still's disease in clinical practice. Autoimmunity Reviews 16:10, pages 1016-1023.
Crossref
Crossref
A. Wehr, G. Grieb, C. Trautwein & K. Streetz. (2017) Unusual onset of adult still’s disease due to a systemic reaction to artificial breast implantsUngewöhnlicher Beginn eines adulten Still-Syndroms aufgrund einer systemischen Reaktion auf Brustimplantate. Zeitschrift für Rheumatologie 76:6, pages 547-549.
Crossref
Crossref
Der-Yuan Chen, Yi-Ming Chen, Han-Ju Chien, Chi-Chen Lin, Chia-Wei Hsieh, Hsin-Hua Chen, Wei-Ting Hung & Chien-Chen Lai. (2016) Metabolic Disturbances in Adult-Onset Still’s Disease Evaluated Using Liquid Chromatography/Mass Spectrometry-Based Metabolomic Analysis. PLOS ONE 11:12, pages e0168147.
Crossref
Crossref
L. Guilleminault, S. Laurent, A. Foucher, P. Poubeau & F. Paganin. (2016) Pulmonary arterial hypertension in adult onset Still’s disease: a case report of a severe complication. BMC Pulmonary Medicine 16:1.
Crossref
Crossref
Nobuo Sakata, Sayuri Shimizu, Fumio Hirano & Kiyohide Fushimi. (2016) Epidemiological study of adult-onset Still’s disease using a Japanese administrative database. Rheumatology International 36:10, pages 1399-1405.
Crossref
Crossref
Filippo Lococo, Gianluigi Bajocchi, Andrea Caruso, Riccardo Valli, Tommaso Ricchetti, Giorgio Sgarbi & Carlo Salvarani. (2016) Occasional detection of thymic epithelial tumor 4 years after diagnosis of adult onset Still disease. Medicine 95:36, pages e4357.
Crossref
Crossref
Santos Castañeda, Esther F. Vicente & Miguel A. González-Gay. (2016) Enfermedad de Still del adulto. Medicina Clínica 147:5, pages 217-222.
Crossref
Crossref
Santos Castañeda, Esther F. Vicente & Miguel A. González-Gay. (2016) Adult-onset Still's disease. Medicina Clínica (English Edition) 147:5, pages 217-222.
Crossref
Crossref
Umut Kalyoncu, Dilek Solmaz, Hakan Emmungil, Ayten Yazici, Timucin Kasifoglu, Gezmiş Kimyon, Ayşe Balkarli, Cemal Bes, Mustafa Ozmen, Fatma Alibaz-Oner, Sükran Erten, Yonca Cagatay, Gözde Yıldırım Cetin, Sedat Yilmaz, Fatih Yildiz, Omer Nuri Pamuk, Orhan Kucuksahin, Levent Kilic, Veli Yazisiz, Omer Karadag, Süleyman Serdar Koca, Mutlu Hayran, Servet Akar, Kenan Aksu, Nurullah Akkoc, Gokhan Keser, Emel Gonullu, Bunyamin Kisacik, Ahmet Mesut Onat, Mehmet Soy, Nevsun Inanc, Haner Direskeneli, Mehmet Sayarlioglu, Eren Erken, Murat Turgay, Ayse Cefle, Ihsan Ertenli & Salih Pay. (2016) Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort. Journal of Autoimmunity 69, pages 59-63.
Crossref
Crossref
Katharina Hofheinz, Georg Schett & Bernhard Manger. (2016) Adult onset Still’s disease associated with malignancy—Cause or coincidence?. Seminars in Arthritis and Rheumatism 45:5, pages 621-626.
Crossref
Crossref
Santos Castañeda, Ricardo Blanco & Miguel A. González-Gay. (2016) Adult-onset Still's disease: Advances in the treatment. Best Practice & Research Clinical Rheumatology 30:2, pages 222-238.
Crossref
Crossref
Eri Watanabe, Hitoshi Sugawara, Takeshi Yamashita, Akira Ishii, Aya Oda & Chihiro Terai. (2016) Successful Tocilizumab Therapy for Macrophage Activation Syndrome Associated with Adult-Onset Still’s Disease: A Case-Based Review. Case Reports in Medicine 2016, pages 1-7.
Crossref
Crossref
M. Gerfaud-Valentin, P. Sève, A. Hot, C. Broussolle & Y. Jamilloux. (2015) Données actualisées sur la physiopathologie, les phénotypes et les traitements de la maladie de Still de l’adulte. La Revue de Médecine Interne 36:5, pages 319-327.
Crossref
Crossref
Madiha Mahfoudhi, Imen Gorsane, Amel Gaieb Battikh, Rafik Shimi, Sami Turki, Fathi Ben Hamida & Taïeb Ben Abdallah. (2015) Adult Onset Still’s Disease: Articular Manifestations in Twenty Cases. Open Journal of Clinical Diagnostics 05:02, pages 41-45.
Crossref
Crossref
Elena Riera Alonso & Alejandro Olivé. 2015. Rheumatology. Rheumatology
720
726
.
Suat Ali Doğan, Süleyman Durmaz, Orhan Yıldız, Gökhan Metan, Selma Gökahmetoğlu, Salih Özgöçmen & Murat Karauz. (2014) A Case of Adult Still’s Disease Trigger by Borrelia garinii. European Journal of Basic Medical Sciences 4:4, pages 95-99.
Crossref
Crossref
Mathieu Gerfaud-Valentin, Yvan Jamilloux, Jean Iwaz & Pascal Sève. (2014) Adult-onset Still's disease. Autoimmunity Reviews 13:7, pages 708-722.
Crossref
Crossref
D. Holzinger, H. Becker & A.M. Jacobi. (2013) Interleukin-1-vermittelte ErkrankungenInterleukin-1-mediated diseases. Der Internist 54:4, pages 408-415.
Crossref
Crossref
Xiao-chun SHI, Xiao-qing LIU, Bao-tong ZHOU, Li-fan ZHANG, Xiao-jun MA, Guo-hua DENG, Tai-sheng LI, Rui-yuan SHENG & Ai-xia WANG. (2013) Major causes of fever of unknown origin at Peking Union Medical College Hospital in the past 26 years. Chinese Medical Journal 126:5, pages 808-812.
Crossref
Crossref
Qinjin Hu, Zhencheng Yan & Jian Zhong. (2011) Adult-onset Still’s disease: how to make a diagnosis in an atypical case. Rheumatology International 32:10, pages 3299-3302.
Crossref
Crossref
Hyoun-Ah Kim, Jun-Mo Sung & Chang-Hee Suh. (2011) Therapeutic responses and prognosis in adult-onset Still’s disease. Rheumatology International 32:5, pages 1291-1298.
Crossref
Crossref
R. Li, J. Sun, L.-M. Ren, H.-Y. Wang, W.-H. Liu, X.-W. Zhang, S. Chen, R. Mu, J. He, Y. Zhao, L. Long, Y.-Y. Liu, X. Liu, X.-L. Lu, Y.-H. Li, S.-Y. Wang, S.-S. Pan, C. Li, H.-Y. Wang & Z.-G. Li. (2011) Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing. Rheumatology 51:4, pages 721-729.
Crossref
Crossref
LINDI JIANG, ZHEN WANG, XIAOMIN DAI & XUEJUAN JIN. (2011) Evaluation of Clinical Measures and Different Criteria for Diagnosis of Adult-onset Still’s Disease in a Chinese Population. The Journal of Rheumatology 38:4, pages 741-746.
Crossref
Crossref
Johannes C. Nossent. 2011. Rheumatology. Rheumatology
849
858.e1
.
Juan Carlos Duró Pujol. 2010. Reumatología Clínica. Reumatología Clínica
461
463
.
P. Lamprecht. (2009) Adulter Morbus Still, Schnitzler-Syndrom und autoinflammatorische Syndrome im ErwachsenenalterAdult-onset Still’s disease, Schnitzler syndrome, and autoinflammatory syndromes in adulthood. Zeitschrift für Rheumatologie 68:9, pages 740-746.
Crossref
Crossref
TING ZENG, YU-QIONG ZOU, MEI-FANG WU & CHENG-DE YANG. (2009) Clinical Features and Prognosis of Adult-onset Still’s Disease: 61 Cases from China. The Journal of Rheumatology 36:5, pages 1026-1031.
Crossref
Crossref
SANG-WON LEE, YONG-BEOM PARK, JUNG-SOO SONG & SOO-KON LEE. (2009) The Mid-Range of the Adjusted Level of Ferritin Can Predict the Chronic Course in Patients with Adult Onset Still’s Disease. The Journal of Rheumatology 36:1, pages 156-162.
Crossref
Crossref
B. Manger. (2008) Der adulte Morbus StillAdult onset Still’s disease. Zeitschrift für Rheumatologie.
Crossref
Crossref
Yoon‐Kyoung SUNG, Sang‐Seokg SEONG, Jin‐Hyun WOO, Myung‐Ho LEE, Won‐Tae CHUNG, Jeong‐Yoon CHOE & Dae‐Hyun YOO. (2008) TNF‐α polymorphisms in Korean adult‐onset Still's disease patients. International Journal of Rheumatic Diseases 11:2, pages 155-162.
Crossref
Crossref
Luis Carreño Pérez & Francisco Javier López Longo. (2007) Enfermedad de Still del adulto. Medicina Clínica 129:7, pages 255-257.
Crossref
Crossref
Sukhbir Singh Uppal, Moudhi Al-Mutairi, Sawsan Hayat, Mini Abraham & Anand Malaviya. (2006) Ten years of clinical experience with adult onset Still’s disease: is the outcome improving?. Clinical Rheumatology 26:7, pages 1055-1060.
Crossref
Crossref